Caixin

China Private Equity Enters Consolidation Phase as Fundraising Crunch Persists

Published: Apr. 21, 2026  10:54 p.m.  GMT+8
00:00
00:00/00:00
Listen to this article 1x
Bain survey data shows a significant improvement in market sentiment for 2025. Photo: VCG
Bain survey data shows a significant improvement in market sentiment for 2025. Photo: VCG

China’s private equity market recorded its second consecutive year of transaction growth in 2025, even as severe fundraising bottlenecks signal the end of the industry’s rapid expansion phase.

The findings, detailed in Bain & Co.’s 2026 China private equity market report released on Tuesday, highlight an industry shifting into a consolidation period driven by macroeconomic stabilization.

loadingImg
You've accessed an article available only to subscribers
VIEW OPTIONS

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to Save an extra $50. Introductory offer for new readers. Subscribe now.

Share this article
Open WeChat and scan the QR code
DIGEST HUB
Digest Hub Back
Explore the story in 30 seconds
  • China’s PE market had 2nd year of transaction growth in 2025, but fundraising fell; USD funds raised ~$4B, down 2% YoY.
  • Shift to buyouts (33% from 9% in 2022); top 10 GPs took 80% fundraising; LP co-investments hit 78%.
  • Median EV/EBITDA rose to 12.1 (2023-2025) from 11.9; 20% IRR needs 12% annual EBITDA growth vs 5% a decade ago.
AI generated, for reference only
Who’s Who
Bain & Company
Bain & Company released its 2026 China Private Equity Market Report, highlighting two years of transaction growth amid fundraising bottlenecks and industry consolidation. Global partners Chen Jie and Zhou Hao discussed valuation recovery (median EV/EBITDA at 12.1), LP trends, exit pressures, and a shift to buyouts.
AI generated, for reference only
Subscribe to unlock Digest Hub
SUBSCRIBE NOW
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Darers & Doers Podcast: The Quest for AI-Powered Cancer Vaccines
00:00
00:00/00:00